[SCIENTX] YoY TTM Result on 31-Jan-2021 [#2]

Stock
[SCIENTX] SCIENTEX BERHAD
Announcement Date
09-Mar-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Jul-2021
Quarter
31-Jan-2021 [#2]
Profit Trend
QoQ- 3.66%
YoY- 8.23%
Quarter Report
Latest QR
Upcoming QR
SCIENTX's Result
SCIENTX's Financial Summary
View:
Show?
TTM Result
31/01/24 31/01/23 31/01/22 31/01/21 31/01/20 31/01/19 31/01/18 CAGR
Revenue 4,267,873 4,113,407 3,827,341 3,435,662 3,558,965 2,813,557 2,575,653 8.77%
PBT 663,905 571,986 577,887 566,480 533,340 356,297 347,666 11.37%
Tax -152,572 -120,798 -105,955 -120,668 -125,351 -73,456 -64,728 15.35%
NP 511,333 451,188 471,932 445,812 407,989 282,841 282,938 10.36%
-
NP to SH 503,528 426,781 449,094 416,377 384,722 276,834 279,007 10.33%
-
Tax Rate 22.98% 21.12% 18.33% 21.30% 23.50% 20.62% 18.62% -
Total Cost 3,756,540 3,662,219 3,355,409 2,989,850 3,150,976 2,530,716 2,292,715 8.57%
-
Net Worth 3,598,779 3,241,677 2,946,666 2,698,034 2,356,091 1,843,805 1,635,984 14.03%
Dividend
31/01/24 31/01/23 31/01/22 31/01/21 31/01/20 31/01/19 31/01/18 CAGR
Div 155,106 139,589 139,554 118,651 102,457 97,785 75,852 12.65%
Div Payout % 30.80% 32.71% 31.07% 28.50% 26.63% 35.32% 27.19% -
Equity
31/01/24 31/01/23 31/01/22 31/01/21 31/01/20 31/01/19 31/01/18 CAGR
Net Worth 3,598,779 3,241,677 2,946,666 2,698,034 2,356,091 1,843,805 1,635,984 14.03%
NOSH 1,551,267 1,551,063 1,550,999 1,550,594 515,876 489,233 488,926 21.20%
Ratio Analysis
31/01/24 31/01/23 31/01/22 31/01/21 31/01/20 31/01/19 31/01/18 CAGR
NP Margin 11.98% 10.97% 12.33% 12.98% 11.46% 10.05% 10.99% -
ROE 13.99% 13.17% 15.24% 15.43% 16.33% 15.01% 17.05% -
Per Share
31/01/24 31/01/23 31/01/22 31/01/21 31/01/20 31/01/19 31/01/18 CAGR
RPS 275.13 265.20 246.79 221.57 690.32 575.28 532.14 -10.40%
EPS 32.46 27.52 28.96 26.85 74.62 56.60 57.64 -9.12%
DPS 10.00 9.00 9.00 7.65 20.00 20.00 15.67 -7.20%
NAPS 2.32 2.09 1.90 1.74 4.57 3.77 3.38 -6.07%
Adjusted Per Share Value based on latest NOSH - 1,550,594
31/01/24 31/01/23 31/01/22 31/01/21 31/01/20 31/01/19 31/01/18 CAGR
RPS 274.24 264.31 245.93 220.76 228.69 180.79 165.50 8.77%
EPS 32.35 27.42 28.86 26.75 24.72 17.79 17.93 10.33%
DPS 9.97 8.97 8.97 7.62 6.58 6.28 4.87 12.67%
NAPS 2.3124 2.083 1.8934 1.7337 1.5139 1.1848 1.0512 14.03%
Price Multiplier on Financial Quarter End Date
31/01/24 31/01/23 31/01/22 31/01/21 31/01/20 31/01/19 31/01/18 CAGR
Date 31/01/24 31/01/23 31/01/22 29/01/21 31/01/20 31/01/19 30/01/18 -
Price 4.00 3.53 4.59 3.99 9.05 8.80 8.75 -
P/RPS 1.45 1.33 1.86 1.80 1.31 1.53 1.64 -2.03%
P/EPS 12.32 12.83 15.85 14.86 12.13 15.55 15.18 -3.41%
EY 8.12 7.79 6.31 6.73 8.25 6.43 6.59 3.53%
DY 2.50 2.55 1.96 1.92 2.21 2.27 1.79 5.72%
P/NAPS 1.72 1.69 2.42 2.29 1.98 2.33 2.59 -6.59%
Price Multiplier on Announcement Date
31/01/24 31/01/23 31/01/22 31/01/21 31/01/20 31/01/19 31/01/18 CAGR
Date 26/03/24 15/03/23 16/03/22 09/03/21 11/03/20 19/03/19 22/03/18 -
Price 3.91 3.51 3.93 4.00 8.92 8.46 8.03 -
P/RPS 1.42 1.32 1.59 1.81 1.29 1.47 1.51 -1.01%
P/EPS 12.05 12.76 13.57 14.90 11.95 14.95 13.93 -2.38%
EY 8.30 7.84 7.37 6.71 8.37 6.69 7.18 2.44%
DY 2.56 2.56 2.29 1.91 2.24 2.36 1.95 4.63%
P/NAPS 1.69 1.68 2.07 2.30 1.95 2.24 2.38 -5.54%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment